• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, May 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Certain psychiatric drugs linked with elevated pneumonia risk

Bioengineer by Bioengineer
January 9, 2019
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A review of published studies indicates that use of benzodiazepines and benzodiazepine related drugs (BZRDs), which are prescribed to treat various psychiatric diseases, may increase the risk of pneumonia.

The International Journal of Geriatric Psychiatry analysis included 12 reports related to 10 studies involving more than 120,000 pneumonia cases. After pooling the estimates, the odds for developing pneumonia were 1.25-fold higher in BZRD users compared with individuals who had not taken BZRDs.

There was an increased risk of pneumonia among current and recent users, but not past users.

###

Media Contact
Penny Smith
[email protected]
http://dx.doi.org/10.1002/gps.5048

Tags: DrugsMedicine/HealthMental HealthPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

PSU-Led Team Advances Promising New Drug Candidate for Malaria Control and Eradication — Medicine

PSU-Led Team Advances Promising New Drug Candidate for Malaria Control and Eradication

May 13, 2026

Study Finds Increased Psychosis Risk in High-Risk Groups with Combined Cannabis and Tobacco Use

May 13, 2026

Study Suggests Possible Link Between Mother’s Occupation and Autism Spectrum Disorder in Children

May 13, 2026

Combined Exercise and HIIT Significantly Reduce 24-Hour Blood Pressure, New Study Shows

May 13, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    842 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    728 shares
    Share 290 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

PSU-Led Team Advances Promising New Drug Candidate for Malaria Control and Eradication

Study Finds Increased Psychosis Risk in High-Risk Groups with Combined Cannabis and Tobacco Use

Study Suggests Possible Link Between Mother’s Occupation and Autism Spectrum Disorder in Children

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.